SEC 13F Intelligence

Avidity Partners Management LP / RCKT

Avidity Partners Management LP’s Rocket Pharmaceuticals Inc Position

Does Avidity Partners Management LP own Rocket Pharmaceuticals Inc (RCKT)? Not currently — the last reported position was 1.05M shares worth $13M in Q4 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$13M
Q4 2024
Shares
1.05M
% of Portfolio
+1.30%
Quarters Held
10
position exited

Position History RCKT

Reported value by quarter
Q4 ’20: $3MQ4 ’20Q4 ’22: $30MQ1 ’23: $21MQ1 ’23Q2 ’23: $26MQ3 ’23: $33MQ3 ’23Q4 ’23: $52MQ1 ’24: $28MQ1 ’24Q2 ’24: $24MQ3 ’24: $14MQ3 ’24Q4 ’24: $13Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q4 20241.05M$13M+1.30%
Q3 2024749.0K$14M+0.71%
Q2 20241.10M$24M+1.01%
Q1 20241.02M$28M+0.89%
Q4 20231.72M$52M+1.88%
Q3 20231.59M$33M+1.31%
Q2 20231.33M$26M+0.92%
Q1 20231.24M$21M+0.71%
Q4 20221.53M$30M+0.65%
Q4 202050.0K$3M+0.09%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Avidity Partners Management LP’s full portfolio or all institutional holders of RCKT.